| Financial Year End | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Revenue | 15.44B | 14.95B | 15.05B | 14.47B | 14.32B |
| Cost of Revenue | 6.80B | 6.67B | 6.63B | 6.62B | 6.66B |
| Gross Profit | 8.64B | 8.29B | 8.42B | 7.85B | 7.66B |
| Operating Expenses | 6.13B | 5.62B | 5.41B | 4.86B | 5.26B |
| Selling, General & Admin | 5.68B | 5.63B | 5.48B | 4.96B | 5.20B |
| Research & Development | 399.00M | 375.00M | 355.00M | 320.00M | 391.00M |
| Other Operating Expenses | 50.00M | 4.00M | 25.00M | 3.00M | 59.00M |
| Operating Income | 2.51B | 2.67B | 2.92B | -979.00M | 1.85B |
| Other Expenses / Income | -322.00M | -38.00M | 5.00M | -37.00M | 274.00M |
| Before Tax Income | 2.19B | 2.64B | 2.92B | -1.02B | 2.12B |
| Income Tax Expenses | 526.00M | 550.00M | 894.00M | -137.00M | 685.00M |
| Net Income | 1.66B | 2.06B | 2.08B | -879.00M | 1.44B |
| Interest Expenses | 358.00M | N/A | N/A | N/A | N/A |
| Basic Shares Outstanding | 1.85B | 1.91B | 1.89B | 1.89B | 1.89B |
| Diluted Shares Outstanding | 1.92B | 1.91B | 1.89B | 1.89B | 1.89B |
| EBITDA | 3.17B | 3.64B | 3.87B | 3.79B | 3.28B |
| EBITDA Margin | 20.56% | 24.33% | 25.73% | 26.21% | 22.91% |
| EBIT | 2.55B | 2.61B | 2.97B | -1.02B | 2.12B |
| EBIT Margin | 16.50% | 17.48% | 19.74% | -7.02% | 14.80% |
| Financial Year End | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |